Martin Brecher, MD
VP, Clinical Development, NeuroRx, Inc. · NRx Pharma · AstraZeneca
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Martin Brecher, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:55 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT03396601 · NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar DepressionNeuroRx, Inc. · unknown · Bipolar Depression, Suicidal Ideation · study director
- Ph2/Ph3NCT03395392 · NRX-101 for Bipolar Depression With Subacute Suicidal IdeationNeuroRx, Inc. · completed · Bipolar Depression, Suicidal Ideation and Behavior · study director
- Ph3NCT03396068 · NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal IdeationNeuroRx, Inc. · unknown · Bipolar Depression, Suicidal Ideation · study director
- Ph3NCT00534599 · Generalized Anxiety Disorder Adjunct StudyAstraZeneca · completed · Anxiety, Anxiety Disorders, Anxiety Neuroses · study director
- Ph3NCT00314210 · Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.AstraZeneca · completed · Anxiety Disorders · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.